| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Bone and Mineral Research Unit, Veterans Affairs Medical Center, (K.M.W., X.Z., E.S.O.) Portland, Oregon 97201; and the Departments of Behavioral Neuroscience (K.M.W.), Cell and Developmental Biology (K.M.W.), Medicine (K.M.W. and E.S.O.), and Physiology and Pharmacology (E.K and B.R.), Oregon Health Sciences University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Dr. Kristine Wiren, Portland VA Medical Center P3R&D39, 3710 SW Veterans Hospital Road, Portland, Oregon 97201. E-mail: wirenk{at}ohsu.edu
Although androgens have myriad effects on the skeleton, the regulation of androgen action in bone is not well understood. Androgen receptors (ARs) are known to play an important role in mediating androgen action. We have examined the effects of androgens and other sex steroids on AR levels in osteoblastic cells in vitro using two clonal human cell lines, SaOS-2 and U-2 OS. AR protein levels were quantitated both by specific androgen binding studies and Western analyses, and AR messenger RNA was measured with RNase protection assays. Potential changes in AR functionality was assessed by reporter assays.
Treatment of osteoblastic cells with the nonaromatizable androgen
5
-dihydrotestosterone (DHT) increased specific androgen binding 2-
to 4-fold. Similar increases in AR protein levels were documented by
Western analysis in both cell lines. The androgen-mediated increase in
receptor levels was time and dose dependent as well as androgen
specific. Steady-state AR messenger RNA levels were also increased by
DHT. When AR concentrations in osteoblastic cells were elevated with
exogenous receptor, there was an enhancement of DHT responsiveness,
measured by increased trans-activation of an
androgen-responsive promoter.
Thus, androgen exposure increased androgen receptor protein levels and specific androgen binding in osteoblastic cells. Androgen action as measured by androgen-mediated transcriptional activation is enhanced in the presence of elevated AR levels. Consequently, these studies have revealed an additional means by which androgens may modulate skeletal metabolism.
This article has been cited by other articles:
![]() |
P. Zhou, B. Shah, K. Prasad, and R. David Letrozole Significantly Improves Growth Potential in a Pubertal Boy With Growth Hormone Deficiency Pediatrics, February 1, 2005; 115(2): e245 - e248. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benito, B. Gomberg, F. W. Wehrli, R. H. Weening, B. Zemel, A. C. Wright, H. K. Song, A. Cucchiara, and P. J. Snyder Deterioration of Trabecular Architecture in Hypogonadal Men J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1497 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grad, L. S. Lyons, D. M. Robins, and K. L. Burnstein The Androgen Receptor (AR) Amino-Terminus Imposes Androgen-Specific Regulation of AR Gene Expression via an Exonic Enhancer Endocrinology, March 1, 2001; 142(3): 1107 - 1116. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |